Current Report Filing (8-k)
July 07 2021 - 4:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
July 6, 2021
ALLIED
HEALTHCARE PRODUCTS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
0-19266
|
|
25-1370721
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices)
|
|
63110
(Zip Code)
|
Registrant’s telephone number, including area code
|
(314) 771-2400
|
|
Not applicable
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR §240.12b-2).
Emerging Growth
Company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b)
of the Act:
Title of Each Class
|
|
Trading Symbol
|
|
Name of Each Exchange on Which
Registered
|
Common Stock, $.01
|
|
AHPI
|
|
The NASDAQ Stock Market, LLC
|
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
|
(c) Appointment of New Principal Operating Officer.
On July 6, 2021, Allied Healthcare Corporation, Inc. (the “Company”) appointed Kevin Kroupa as Vice President of Operations.
Mr. Kroupa is 62 years old and has over 40 years of experience in engineering, manufacturing and management. Since 2002 Mr. Kroupa has
been employed by the Company in the position of Vice-President of Engineering. As Vice President – Operations, Mr. Kroupa will assume
broader responsibility the Company’s manufacturing operations.
Pursuant to the terms of his employment, Mr. Kroupa
is entitled to annual compensation of $237,805.00 as well as perquisites that the Company makes available to other similarly situated
employees, including without limitation a car allowance of $12,195.00 per annum.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
ALLIED HEALTHCARE PRODUCTS, INC.
|
|
|
Date: July 7, 2021
|
By:
|
/s/ Daniel C. Dunn
|
|
|
Daniel C. Dunn
|
|
|
Chief Financial Officer
|
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Sep 2023 to Sep 2024